U.S., June 18 -- ClinicalTrials.gov registry received information related to the study (NCT07025044) titled 'Assessing the Genitourinary Microbiome of Women With Overactive Bladder Undergoing Onabotulinum Toxin Type A Intradetrusor Injections' on June 02.

Brief Summary: Single-site prospective observational pilot feasibility study of women with overactive bladder/urge urinary incontinence undergoing onabotulinum toxin type A intradetrusor injections in order to achieve the following objectives:

* Establish a record of successful collaboration with Dr. Ravel, an expert researcher in the female microbiome based at the University of Maryland

* Demonstrate the investigators' ability to recruit subjects from the diverse population of postmeno...